Slovenien - slovenska - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

mylan healthcare d.o.o. - trandolapril - kapsula, trda - trandolapril 4 mg / 1 kapsula - trandolapril

Slovenien - slovenska - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

pharmaswiss Česká republika s.r.o. - trandolapril - kapsula, trda - trandolapril 4 mg / 1 kapsula - trandolapril

Slovenien - slovenska - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

pharmaswiss Česká republika s.r.o. - trandolapril - kapsula, trda - trandolapril 0,5 mg / 1 kapsula - trandolapril

Slovenien - slovenska - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

pharmaswiss Česká republika s.r.o. - trandolapril - kapsula, trda - trandolapril 2 mg / 1 kapsula - trandolapril

Slovenien - slovenska - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

mylan healthcare d.o.o. - trandolapril; verapamil - tableta s podaljšanim sproščanjem - trandolapril 2 mg / 1 tableta  verapamil166,6 mg / 1 tableta; verapamil 166,6 mg / 1 tableta - trandolapril in verapamil

Slovenien - slovenska - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

mylan healthcare d.o.o. - trandolapril; verapamil - tableta s podaljšanim sproščanjem - trandolapril 4 mg / 1 tableta  verapamil222,19 mg / 1 tableta; verapamil 222,19 mg / 1 tableta - trandolapril in verapamil

Europeiska unionen - slovenska - EMA (European Medicines Agency)

biosimilar collaborations ireland limited - pegfilgrastim - nevtropenija - immunostimulants, - skrajšanje trajanja nevtropenija in pojavnost vročinskih nevtropenija pri odraslih bolnikih, zdravljenih s citotoksično kemoterapijo za malignosti (razen kronično mieloično levkemijo in mielodisplastični sindrom).

Europeiska unionen - slovenska - EMA (European Medicines Agency)

atnahs pharma netherlands b.v. - ibandronska kislina - osteoporoza, postmenopavz - zdravila za zdravljenje bolezni kosti - zdravljenje osteoporoze pri ženskah po menopavzi na povečano tveganje za zlome (glej poglavje 5. zmanjšanje tveganja za zlome vretenc je bilo dokazano, učinkovitosti na vratu femoralne zlome ni bila ugotovljena.

Europeiska unionen - slovenska - EMA (European Medicines Agency)

accord healthcare s.l.u. - doxorubicin hydrochloride, liposomal - ovarian neoplasms; sarcoma, kaposi; multiple myeloma - doxorubicin - zolsketil pegylated liposomal is a medicine used to treat the following types of cancer in adults:• breast cancer that has spread to other parts of the body in patients at risk of heart problems. zolsketil pegylated liposomal is used on its own for this disease;• advanced ovarian cancer in women whose previous treatment including a platinum-based cancer medicine has stopped working;• multiple myeloma (a cancer of the white blood cells in the bone marrow), in patients with progressive disease who have received at least one other treatment in the past and have already had, or are unsuitable for, a bone marrow transplantation. zolsketil pegylated liposomal is used in combination with bortezomib (another cancer medicine);• kaposi’s sarcoma in patients with aids who have a very damaged immune system. kaposi’s sarcoma is a cancer that causes abnormal tissue to grow under the skin, on moist body surfaces or on internal organs. zolsketil pegylated liposomal contains the active substance doxorubicin and is a ‘hybrid medicine’. this means that it is similar to a ‘reference medicine’ containing the same active substance called adriamycin. however, in zolsketil pegylated liposomal the active substance is enclosed in tiny fatty spheres called liposomes, whereas this is not the case for adriamycin.

Slovenien - slovenska - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

sandoz d.d. - zonisamid - kapsula, trda - zonisamid 50 mg / 1 kapsula - zonisamid